Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
10/1998
10/08/1998WO1998043478A1 Identification of polynucleotides encoding novel helicobacter polypeptides in the helicobacter genome
10/08/1998WO1998020124A3 Diabetes-mediating proteins and therapeutic uses thereof
10/08/1998WO1998020027A3 Therapeutic use of an agent that stimulates no or prostacyclin production and delivery device
10/08/1998CA2286306A1 Identification of polynucleotides encoding novel helicobacter polypeptides in the helicobacter genome
10/08/1998CA2285923A1 Methods and compositions for treating inflammatory bowel disease
10/08/1998CA2285903A1 Biodegradable terephthalate polyester-poly(phosphate) polymers, compositions, articles, and methods for making and using the same
10/08/1998CA2285631A1 Antioxidant protein 2, gene and methods of use therefor
10/08/1998CA2284940A1 Use of sodium channel blocker in the manufacture of a medicament for preventing optic nerve degeneration associated with glaucoma
10/08/1998CA2283799A1 Novel human serine carboxypeptidase
10/08/1998CA2283097A1 Use of inhibitors of undecaprenol kinase to inhibit cell wall biosynthesis
10/07/1998EP0869180A1 A TNF homologue, TL5
10/07/1998EP0869179A1 Tumor necrosis related receptor, TR7
10/07/1998EP0869178A1 SAF-3, Sialoadhesin family member-3
10/07/1998EP0868914A1 Pharmaceutical composition for the control and treatment of anorectal and colonic diseases
10/07/1998EP0868532A1 METHODS FOR DETERMINING COMPOUNDS CAPABLE OF INHIBITING THE ACTIVITIES OF THE Ha-ras ONCOGENE
10/07/1998EP0868518A1 Staphylococcus aureus coenzyme a disulfide reductase, and inhibitors thereof useful as antimicrobial agents
10/07/1998EP0868516A1 Novel tcts response regulator of staphylococcus aureus
10/07/1998EP0868513A1 TGF$g(b) SIGNAL TRANSDUCTION PROTEINS, GENES, AND USES RELATED THERETO
10/07/1998EP0868512A2 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer
10/07/1998EP0868194A1 Combination of g-csf with a chemotherapeutic agent for stem cell mobilisation
10/07/1998EP0868191A1 Potentiation of complement and coagulation inhibitory properties of c1-inhibitor.
10/07/1998EP0868176A1 Aminoguanidine for treating niddm
10/07/1998EP0868175A1 Nitric oxide (no) synthase inhibitor to treat or prevent type ii diabetes
10/07/1998EP0700282B1 Inhibition of hair growth
10/07/1998EP0616524B1 Medicaments
10/07/1998CN1195295A Method and use of connective tissue growth factor as revellent
10/07/1998CN1195292A Food and its manufacturing method
10/07/1998CN1195288A Use of fluconazole for inhibiting growth of cancers
10/06/1998US5817912 Transgenic mice with disrupted NPY Y1 receptor genes
10/06/1998US5817771 Cell-targeted lytic pore-forming agents
10/06/1998US5817664 Uracil reductase inactivators
10/06/1998US5817650 Treatment of systemic lupus erythematosus with dehydroepiandrosterone
10/06/1998US5817649 Administering reductase inhibitor and an androgen receptor antagonist
10/06/1998US5817644 Targeting of dosages of medicine and therapeutic agents
10/06/1998US5817642 Administering mixture of chelate compound, non-steroid antiinflammatory agents, antioxidant and hyaluronic acid
10/06/1998US5817632 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
10/06/1998US5817631 Therapeutic uses of melanin
10/06/1998US5817494 Anticancer agents; viricides
10/06/1998US5817486 Recombinant human interleukin-3 (IL-3) multiple mutation polypeptides
10/06/1998US5817485 Nucleic acids and cells for recombinant production of fibroblast growth factor-10
10/06/1998US5817481 Medical diagnosis; detecting diseases related to mutants in nucleic acid sequences and altered concentration of polypeptides
10/06/1998US5817480 DNA encoding a histamine H2 receptor
10/06/1998US5817321 Biological agent compositions
10/06/1998CA1340071C Dectection of infectious and inflammatory lesions using anti-leukocyte conjugates
10/02/1998CA2233787A1 Sialoadhesin family member-3
10/02/1998CA2233785A1 Tumor necrosis related receptor, tr7
10/02/1998CA2232743A1 A tnf homologue, tl5
10/02/1998CA2223021A1 Novel human neurotensin receptor type 2 and splice variants thereof
10/01/1998WO1998043094A1 METHODS TO IDENTIFY β-AMYLOID REDUCING AGENTS
10/01/1998WO1998042849A1 Keratinocyte derived kallikrein
10/01/1998WO1998042725A1 Methods and compositions for diagnosis and treatment of breast cancer
10/01/1998WO1998042384A1 Methods for delivering bioactive agents
10/01/1998WO1998042381A1 Immobilized activity stabilized lhrh antagonist complexes, method for the production thereof
10/01/1998WO1998042377A1 Preventives or remedies for sensitized t cell-related diseases containing il-6 antagonists as the active ingredient
10/01/1998WO1998042353A1 Modulation of human mast cell activation
10/01/1998WO1998042349A1 Mixtures of at least two reverse transcriptase inhibitors and hydroxycarbamide, in particular for inhibiting retroviral spread
10/01/1998WO1998042347A1 Pharmaceutical composition containing a phosphorylamide and an ayntibiotic
10/01/1998WO1998042344A1 Pharmaceutical composition
10/01/1998WO1998042340A1 Retinoid related molecules for the treatment of non-insulin dependent diabetes mellitus
10/01/1998WO1998042318A1 Pellets having a core coated with an antifungal and a polymer
10/01/1998WO1998042296A2 Compositions and methods for diagnosing/treating disease based on beta-catenin/transcription factor interactions
10/01/1998WO1998042275A1 Method of treatment of migraine
10/01/1998WO1998042188A1 Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases
10/01/1998WO1998029555A3 Cytopathic viruses for therapy and prophylaxis of neoplasia
10/01/1998WO1998024427A3 Compositions and methods for treating or preventing inflammatory diseases
10/01/1998DE19712718A1 Immobilisierte und aktivitätsstabilisierte Komplexe von LHRH-Antagonisten und Verfahren zu deren Herstellung Immobilized and activity-stabilized complexes of LHRH antagonists and methods for their preparation
10/01/1998CA2285394A1 Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases
10/01/1998CA2284687A1 Keratinocyte derived kallikrein
10/01/1998CA2284642A1 Methods and compositions for diagnosis and treatment of breast cancer
10/01/1998CA2284483A1 Mixtures of at least two reverse transcriptase inhibitors and hydroxycarbamide, in particular for inhibiting retroviral spread
10/01/1998CA2284261A1 Methods to identify .beta.-amyloid reducing agents
10/01/1998CA2284192A1 Retinoid related molecules for the treatment of non-insulin dependent diabetes mellitus
10/01/1998CA2283932A1 Compositions and methods for diagnosing/treating disease based on beta-catenin/transcription factor interactions
10/01/1998CA2282275A1 Method of treatment of migraine
09/1998
09/30/1998EP0867509A2 Tumor necrosis related receptor, TR5
09/30/1998EP0867426A2 Modified crystals of a solid edible organic acid
09/30/1998EP0867192A2 Combinatory compositions for the treatment of dementia containing at least a compound having acetylcholinesterase-inhibitory or muscarinic activity and a compound that enhances the endogenous extracellular adenosine levels
09/30/1998EP0867191A1 Drug composition
09/30/1998EP0867184A1 Use of tiagabine for the treatment of sleep disorders
09/30/1998EP0867182A2 The use of certain NK-1 receptor antagonists for the manufacture of a medicament for treating emesis
09/30/1998EP0867178A1 Non-allosteric GABA A agonists for treating sleep disorders
09/30/1998EP0866861A2 Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands
09/30/1998EP0866857A1 E6 binding proteins
09/30/1998EP0866713A1 Administration media for analgesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compositions containing such media and drugs
09/30/1998EP0866702A1 Method for treating pain
09/30/1998EP0866701A1 Synergistic immunosuppressant composition containing a 2,2'-bi-1h-pyrrole compound
09/30/1998EP0866699A1 The use of cholinesterase inhibitors in the treatment of xerostomia
09/30/1998EP0866695A1 Combinational therapeutic methods employing nitric oxide scavengers
09/30/1998EP0866693A1 Topically applied, structural cellulite treatments
09/30/1998EP0831726A4 Health food product
09/30/1998EP0781092A4 Method of sensitizing tumor cells with adenovirus e1a
09/29/1998US5814667 Use of nitric oxide-releasing compounds as hypoxic cell radiation sensitizers
09/29/1998US5814614 Hydroxypyridone glucose derivatives for removal of aluminum or iron ions
09/29/1998US5814317 Structural alterations of the EGF receptor gene in human gliomas
09/29/1998US5814032 Drug delivery with tape for transdermal delivery and multilayer bandages
09/28/1998CA2233377A1 Nk-1 receptor antagonists for the treatment of delayed emesis
09/24/1998WO1998041641A1 Recombinant antibodies and immunoconjugates targeted to cd-22 bearing cells and tumors
09/24/1998WO1998041639A1 Serine/threonine protein kinase
09/24/1998WO1998041633A1 Human pancreatitis-associated protein, pap-2
09/24/1998WO1998041632A1 Human tumor suppressor
1 ... 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 ... 1151